The holidays are near, and so is the season of eating decadent meals – and sometimes, overeating. Overindulging on food is ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

Hypochondria can, in extreme cases, leave people unable to hold down a job or make it impossible for them to leave the house, ...

If you’re the kind of person who Googles your health symptoms (no judgment!) you may realize that these experiences could ...

Findings from a 3-year analysis demonstrated that among patients treated with tirzepatide, 98.8% remained diabetes free.

Discover Patanjali’s Madhugrit, an Ayurvedic diabetes solution blending natural herbs with scientific research to manage ...

“The technology is now changing people’s lives,” Shen said.

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...